Skip to main content

Year: 2022

Live Oak Bank Tops SBA’s 100 Most Active 7(A) Lenders

WILMINGTON, N.C., Oct. 14, 2022 (GLOBE NEWSWIRE) — Live Oak Bank has been named the most active SBA 7(a) lender by dollar amount by the U.S. Small Business Administration for the fifth year in a row. The results were posted to the SBA website and display the country’s top 100 SBA 7(a) lenders by loan volume for the administration’s 2022 fiscal year, which ended September 30. “Live Oak Bank has the privilege of serving small business owners across the country and the SBA 7(a) program is an essential way to deliver capital to the entrepreneurs supporting the backbone of our economy,” said Live Oak Chairman and CEO James S. (Chip) Mahan III. “We are proud to serve our customers with a high-touch, high-tech approach that puts them at the center of everything we do.” Live Oak approved 1,157 loans from the SBA’s flagship7(a) program...

Continue reading

Dorman Launches 400+ New Motor Vehicle Repair Solutions, Rapidly Expanding Coverage for SUVs, EVs and Heavy-Duty Trucks

COLMAR, Pa., Oct. 14, 2022 (GLOBE NEWSWIRE) — Dorman Products, Inc. (NASDAQ:DORM) is announcing the release of more than 400 new motor vehicle parts, almost half of which are first-to-the-aftermarket exclusives. The new products join a growing catalog of 118,000+ aftermarket solutions that advance Dorman’s mission of giving repair professionals and owners greater freedom to fix passenger, commercial, and recreational vehicles with internal combustion, hybrid, and electric powertrains. The company’s roster of innovative Dorman® OE FIX™ repair solutions is also growing by eighteen new products designed to help save time, save money, or increase reliability. This month features an OE FIX upgraded aluminum thermostat housing assembly (902-3035HP) engineered to match the fit and function of the original equipment plastic housing...

Continue reading

Regulus Announces US$5.0 M Investment From Osisko Gold Royalties

Figure 1 AntaKori Project Claims MapVANCOUVER, British Columbia, Oct. 14, 2022 (GLOBE NEWSWIRE) — Regulus Resources Inc. (“Regulus” or the “Company”, TSX-V: REG, OTCQX: RGLSF) is pleased to announce the completion of a US$5 million investment (the “Investment”) from Osisko Gold Royalties (“Osisko”) in exchange for a net smelter return (“NSR”) ranging from 0.125% to 1.5% on certain claims of the Company’s AntaKori project (“AntaKori”), as well as a right (currently held by Regulus) to buy-back a 1% NSR from a third party on certain claims of AntaKori. Proceeds from the Investment will be used for exploration activities at AntaKori and for general corporate purposes. This Investment is the second completed by Osisko on the AntaKori project. The first was the strategic partnership between Regulus and Osisko...

Continue reading

NBPE Announces Director Declaration

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONSNBPE Announces Director Declaration 1 October 2022 In accordance with the requirements of Listing Rule 9.6.14, NB Private Equity Partners Limited (the “Company”) advises that it has been notified of the following change to directorships in other publicly quoted companies held by a member of the Board. John Falla, a director and audit committee chairman, has informed the Company that he has been appointed as an independent non-executive director of Baker Steel Resources Trust Limited with immediate effect. For further information, please contact: NBPE Investor Relations          +1 214 647 9593 Kaso Legg Communications        +44 (0)20 3995...

Continue reading

GLUCOTRACK ANNOUNCES THE HIRING OF DR. MARK TAPSAK

INDUSTRY VETERAN TO LEAD NEW CONTINUOUS GLUCOSE MONITORING R&D PROGRAM Rutherford, NJ, Oct. 14, 2022 (GLOBE NEWSWIRE) — GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and prediabetes, announced today that Mark Tapsak, PhD, has joined the Company as Vice President of Sensor Technology, effective immediately. Mark brings over 25 years of experience in the diabetes industry as a medical device research scientist, focused on polymer synthesis, polymer characterization, medical device design and intellectual property. At GlucoTrack, he will lead the recently announced R&D program for a novel implantable continuous glucose monitoring system (CGM) for those with Type 1 diabetes. Mark joins the Company from Diabetic Health, Inc., a developer...

Continue reading

Glen Burnie Bancorp Declares 3Q 2022 Dividend

GLEN BURNIE, Md., Oct. 14, 2022 (GLOBE NEWSWIRE) — Glen Burnie Bancorp (NASDAQ: GLBZ), parent company of The Bank of Glen Burnie®, announced that its Board of Directors declared a regular dividend of ten cents ($0.10) per share of common stock at their meeting on October 13, 2022. This action marks the company’s 121st consecutive dividend. The regular dividend is payable on November 7, 2022, to shareholders of record at the close of business on October 24, 2022. Glen Burnie Bancorp, parent company to The Bank of Glen Burnie, currently maintains consolidated assets totaling $415.6 million at September 30, 2022. Founded in 1949, The Bank of Glen Burnie is a community bank with eight branch offices serving Anne Arundel County, MD (www.thebankofglenburnie.com). Certain information contained in this news release, which does not relate...

Continue reading

TUGA Welcomes Lucas Leonardi to Board of Directors

Business-building entrepreneur brings global focus on automotive software VANCOUVER, British Columbia and LISBON, Portugal, Oct. 14, 2022 (GLOBE NEWSWIRE) — TUGA Innovations, Inc. (CSE: TUGA) (FRA: DQ5) (OTC: TUGAF) (“TUGA Innovations,” or the “Company”), which is developing solutions for urban mobility challenges with the TUGA, a new type of electric vehicle (“EV”), is pleased to announce and welcome Mr. Lucas Leonardi to its board of directors with immediate effect. Mr. Leonardi is currently the Automotive Global Accounts Team Director at Amazon Web Services EMEA based in Paris, France. He brings over 25 years of sales & product marketing experience (business development, original equipment manufacturer agreements and profit and loss statement management) in software and related software as a service industry endeavour....

Continue reading

NASCAR Rivals is Available Today – The Officially Licensed Video Game of the 2022 NASCAR Season From Motorsport Games

Motorsport Games’ latest installment of the NASCAR gaming franchise combines aspects of racing rivalries into a single user experienceNASCAR RIVALS IS AVAILABLE TODAY – THE OFFICIALLY LICENSED VIDEO GAME OF THE 2022 NASCAR SEASON FROM MOTORSPORT GAMES NASCAR RIVALS IS AVAILABLE TODAY – THE OFFICIALLY LICENSED VIDEO GAME OF THE 2022 NASCAR SEASON FROM MOTORSPORT GAMESMIAMI, Oct. 14, 2022 (GLOBE NEWSWIRE) — Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games”), a leading racing game developer, publisher and esports ecosystem provider of official motorsport racing series throughout the world, announced today the launch of NASCAR Rivals, exclusive for Nintendo Switch consoles. The officially licensed video game of the 2022 NASCAR Cup Series season, this latest installment of the video game franchise combines the...

Continue reading

HXPN, Inc. announces 2022 Q1, Q2 Revenue, Sheppard Pool Energy Oil Recompletion Flow Test Results, Bayou Villars First Well Recompletion Oil Production Rate.

FRISCO, TEXAS, Oct. 14, 2022 (GLOBE NEWSWIRE) — HXPN, Inc. (OTC PINK: HXPN) (the “Company”), an emerging technology and mineral resources development company, today announced 2022 1st Quarter revenue of $1,175,000, and 2022 2nd Quarter revenue of $640,000, with each resulting from the sale of a net profits interest in its Sheppard Pool Energy investment and its Bayou Villars investment, respectively, with each investment being announced earlier this year. The Company owns 75% of Sheppard Pool Energy. The sale of the net profits interest of the Sheppard Pool Energy recompletion project is one third (1/3rd) of the net profits of the production of the fifteen (15) wells that the Company will re-complete. The sale of the net profits interest of the Bayou Villars recompletion project is one half (1/2) of the net profits of the production...

Continue reading

BMF-219 Enters the Clinic for KRAS Solid Tumors

Biomea Fusion announces FDA clearance of Investigational New Drug (IND) application for covalent menin inhibitor BMF-219 in KRAS solid tumors. Biomea Fusion will now initiate a Phase I/Ib clinical trial (COVALENT-102) of BMF-219 as a monotherapy in patients who have unresectable, locally advanced, or metastatic non-small cell lung cancer (NSCLC), colorectal cancer (CRC) or pancreatic ductal adenocarcinoma (PDAC) with a KRAS mutation. This Phase I/Ib clinical trial will expand BMF-219’s clinical development to solid tumors; Biomea Fusion is currently underway with COVALENT-101, a Phase I clinical trial studying BMF-219 in multiple blood cancers. BMF-219 is the first menin inhibitor to enter clinical trials for the treatment of solid tumors. A targeted pan-KRAS inhibitor has the potential to treat 25-35% of NSCLC, 35-45% of CRC, and approximately...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.